about
Clinical relevance of the Hevea brasiliensis lipid transfer protein Hev b 12IgE-mediated anaphylaxis after first intravenous infusion of cyclosporineMonosensitivity to pangasius and tilapia caused by allergens other than parvalbuminAllergy from giant pumpkin (Cucurbita maxima) is not a fairy tale.In Vitro Diagnosis of Immediate Drug Hypersensitivity Anno 2017: Potentials and LimitationsHereditary angioneurotic edema: review of the literature.Simultaneous oral mite anaphylaxis (pancake syndrome) in a father and daughter and a review of the literature.Coriander anaphylaxis in a spice grinder with undetected occupational allergy.IgE-mediated natural rubber latex allergy: practical considerations for health care workers.IGE-mediated natural rubber latex allergy: an update.In vitro allergy diagnosis: should we follow the flow?CD4+ROR γ t++ and Tregs in a Mouse Model of Diet-Induced Nonalcoholic Steatohepatitis.Haemodialysis-associated anaphylactic and anaphylactoid reactions.Flow-assisted allergy diagnosis: current applications and future perspectives.Anaphylaxis during anaesthesia: diagnostic approach.Hypersensitivity to nadroparin calcium : case report and review of the literature.Hymenoptera venom allergy.Basophil activation test by flow cytometry: present and future applications in allergology.The basophil activation test in immediate drug allergy.The basophil activation test in immediate-type drug allergy.Macadamia nut allergy: 2 case reports and a review of the literature.Hereditary angioedema in childhood: an approach to management.The basophil activation test in the diagnosis of immediate drug hypersensitivity.The in vitro diagnosis of drug allergy: status and perspectives.Component-resolved allergy diagnosis: a new era?Hazelnut allergy: a multi-faced condition with demographic and geographic characteristics.State of the art and perspectives in food allergy (part I): diagnosis.State of the art and perspectives in food allergy (part II): therapy.In vitro diagnosis of Hymenoptera venom allergy and further development of component resolved diagnostics.Allergy to illicit drugs and narcotics.Predictive value of allergy tests for neuromuscular blocking agents: tackling an unmet need.In vitro diagnosis of immediate IgE-mediated drug hypersensitivity: warnings and (unmet) needs.Basophil activation tests: time for a reconsideration.Sensitization to the mammalian oligosaccharide galactose-alpha-1,3-galactose (alpha-gal): experience in a Flemish case series.Molecular allergy diagnosis: status anno 2015.Cannabis Allergy: What do We Know Anno 2015.The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease.Latex anaphylaxis.In vitro Diagnosis of Immediate Drug Hypersensitivity: Should We Go with the Flow.Influence of IL-6, IL-33, and TNF-α on human mast cell activation: Lessons from single cell analysis by flow cytometry.
P50
Q24169988-17805E56-7FD4-4303-83B2-A76DC36C78CDQ28188603-F62FA82E-1E10-4467-847F-C0C1470BDB36Q28276155-D7EAFFDD-A2C4-4271-B542-4DA4DBEABC26Q30380416-101C2145-F71E-479B-9283-F39B39A86D67Q33665147-A2170F48-B025-419A-A6DE-BDE6B1D06736Q33900261-8B020A2F-4E81-4CC1-95F8-5B96BF487DBBQ34472907-EB5E7445-32FF-43D0-B897-EDBAEE887E58Q34553144-A85E8BD5-6C08-4ECA-814E-0ABBF3033B35Q34709603-9AAB33CC-909A-41A2-99A1-0B033CECE35EQ34769524-3C5F73A1-8CBD-4758-8D57-6A84AF6271B2Q35684399-94CA4579-49D7-4B6F-97EC-1DEA5B2191F1Q35855499-DAB38F9E-9A93-4A9C-8075-9E3D41E18433Q36366935-269FF129-C824-40EC-A947-CF9A069BEC8CQ36570543-CB0258B4-BB3F-4299-B0BB-587A6022C7A9Q36794706-3824B05C-A778-4B1A-BDE7-1296077DABD6Q36828048-F7E752B8-80E3-4326-A424-542E0188B1C5Q36932605-70F16520-CA79-48A6-BF1F-BF80785767A3Q37138426-1A081B64-E12F-4C16-96C9-3634362A835AQ37477072-FE95D22F-A9C5-495F-85ED-D5D6359D532EQ37535216-3E051FF6-451B-4966-A17B-3B51C38FA534Q37758690-EB2E6822-DB26-4909-A439-D77DA2D22E36Q37769213-A06F8290-B0B0-435F-A3CE-CAB7487D3C8DQ37877266-A93F5458-ADB5-446F-8077-FF1695ABD85BQ37885398-EF4EFE05-4E1A-48E2-8838-12A8EA69061CQ38000585-0F890ECD-2C32-46F9-AFF4-23BDFBD603A8Q38063218-2D87D0B7-14CD-4862-B506-340F06CB6A7EQ38108869-40F11316-CE3F-4669-BD33-CFAA50DCE3D7Q38108870-8F9721C6-F2D6-423C-BFAF-9C65ADA71B2AQ38184613-C2C788A0-A5CD-4366-834D-DA469103D7CFQ38192754-725C5537-5DAB-4155-AF8A-4BDEE0152D20Q38213529-25DBD5DB-7A7A-484F-9C06-270827BA94C1Q38228926-A6CF9B4A-D2FE-4B42-ADE4-5B77BACC7C41Q38250069-FAE41099-762D-4B26-BEE1-BFAAA8105CFEQ38311683-B1C38730-EE99-496A-8487-E966AFF31C51Q38355443-C7101D46-9649-4B37-A950-27D984EFABA9Q38547867-F6149B3A-85F1-407C-B061-B51FFB1475E2Q38551689-E6413289-11E4-482E-A136-8BAD3914685FQ38574623-8F3CFCE7-67D7-400E-9676-216542E19C45Q38622397-06CCFE16-0FCE-4E6A-AF05-D4DE9216E2E8Q38627886-81D1B206-D6E9-411C-BE61-A26BA9B6850B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Didier G Ebo
@ast
Didier G Ebo
@en
Didier G Ebo
@es
Didier G Ebo
@nl
type
label
Didier G Ebo
@ast
Didier G Ebo
@en
Didier G Ebo
@es
Didier G Ebo
@nl
prefLabel
Didier G Ebo
@ast
Didier G Ebo
@en
Didier G Ebo
@es
Didier G Ebo
@nl
P106
P31
P496
0000-0003-0672-7529